Abdi Ibrahim

Last updated: 29.11.2018


Abdi Ibrahim Ilaç Sanayi ve Ticaret A.S. manufactures and markets pharmaceuticals for customers in Turkey and internationally. It offers antianemic, antibacterial/antiviral, gastrointestinal, nervous system, ophthalmic, and urogenital system drugs; vitamins and minerals; CANMAb, a biosimilar of trastuzumab used for the treatment of Her2+ breast cancer; and respiratory system, cardiovascular system, dermatologic, endocrine and metabolism, and NSAI and myorelaxant products.

Abdi Ibrahim Ilaç Sanayi ve Ticaret A.S. was formerly known as Ibrahim Abdi Barut and changed its name to Abdi Ibrahim Ilaç Sanayi ve Ticaret A.S. in 1975. The company was founded in 1912 and is based in Istanbul, Turkey. It has operations in Kazakhstan, Algeria, Canada, and the United Kingdom.



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here